2021 International Congress on Myeloproliferative Neoplasms

 

2021 International Congress on Myeloproliferative Neoplasms
A

JAK2V617F and Clonal Hematopoiesis

By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Alison Moliterno
By 2021 International Congress on Myeloproliferative Neoplasms FEATURING Alison Moliterno
24 views
December 15, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey
Videos
22:32

Hereditary Erythrocytosis

2021 International Congress on Myeloproliferative Neoplasms

M. McMullin

29 views
21:43

Clonal and Nonclonal Thrombocytosis

2021 International Congress on Myeloproliferative Neoplasms

J. Spivak

42 views
21:07

Persistent Leukocytosis and PV Progression: Prognostic and Therapeut…

2021 International Congress on Myeloproliferative Neoplasms

J. Mascarenhas

14 views
22:50

JAK2V617F and Clonal Hematopoiesis

2021 International Congress on Myeloproliferative Neoplasms

A. Moliterno

24 views
21:36

MPN Stem Cell Fitness and the Link to Clinical Outcomes

2021 International Congress on Myeloproliferative Neoplasms

J. Scandura

23 views
23:26

Candidate Drugs for Preventing MPN Progression

2021 International Congress on Myeloproliferative Neoplasms

R. Hoffman

20 views
19:42

Hot Topics in Hypereosinophilic Syndrome

2021 International Congress on Myeloproliferative Neoplasms

A. Klion

143 views
17:39

Novel Agents of Potential Value in the MPN

2021 International Congress on Myeloproliferative Neoplasms

N. Pemmaraju

13 views
15:12

A Novel Machine Learning-Derived Dynamic Scoring System Predicts Ris…

2021 International Congress on Myeloproliferative Neoplasms

G. Abu-Zeinah

18 views
17:41

Exploiting Iron Metabolism to Treat Polycythemia Vera

2021 International Congress on Myeloproliferative Neoplasms

Y. Ginzburg

14 views
24:03

Inflammation in MPNs: Clinical and Therapeutic Aspects

2021 International Congress on Myeloproliferative Neoplasms

H. Hasselbalch

13 views
20:56

Treatment Approaches for Early MF

2021 International Congress on Myeloproliferative Neoplasms

R. Mesa

310 views
32:24

New ELN Recommendations for CML

2021 International Congress on Myeloproliferative Neoplasms

R. Hehlmann

126 views
17:46

Which Published Schemas Are Helpful in MPN Transplant Decisions?

2021 International Congress on Myeloproliferative Neoplasms

S. Giralt

12 views
22:47

Anticoagulant Management in the MPNs

2021 International Congress on Myeloproliferative Neoplasms

C. Kessler

19 views
20:00

Are Hematologists Rational?

2021 International Congress on Myeloproliferative Neoplasms

R. Gale

21 views
12:42

Pediatric MPNs: An Unfamiliar Topic

2021 International Congress on Myeloproliferative Neoplasms

N. Kucine

15 views
20:20

Role of NGS in the Diagnosis and Prognosis of MPNs

2021 International Congress on Myeloproliferative Neoplasms

A. Vannucchi

248 views
21:09

Update on the Clinical Status of Commonly Used Drugs in Primary MF

2021 International Congress on Myeloproliferative Neoplasms

S. Verstovsek

266 views